Data completeness
1/8 — Limited
PARAFLEX (chlorzoxazone) by Johnson & Johnson is clinical pharmacology chlorzoxazone is a centrally-acting agent for painful musculoskeletal conditions.
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PARAFLEX (chlorzoxazone) is an oral centrally-acting skeletal muscle relaxant indicated for painful musculoskeletal conditions. It works by inhibiting multisynaptic reflex arcs at the spinal cord and subcortical brain levels to reduce muscle spasm, pain, and improve mobility. The drug is rapidly absorbed, peaks within 1–2 hours, and is metabolized and excreted primarily as glucuronide conjugate in urine.
Pre-Launch
Pre-launch stage indicates active build-out of commercial infrastructure; modest team growth expected as launch readiness ramps.
Mechanism of Action
CLINICAL PHARMACOLOGY Chlorzoxazone is a centrally-acting agent for painful musculoskeletal conditions. Data available from animal experiments as well as human study indicate that chlorzoxazone acts primarily at the level of the spinal cord and subcortical areas of the brain where it inhibits…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PARAFLEX during pre-launch offers exposure to full product lifecycle planning, regulatory execution, and go-to-market strategy for an established mechanism in a competitive category. This role builds foundational commercial and strategic competencies as the brand enters market.
Worked on PARAFLEX at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.